Best treatments for relapsing-remitting multiple sclerosis

Understanding relapsing-remitting multiple sclerosis

Multiple sclerosis (MS) is a disease of the central nervous system — the brain and spinal cord — thought to be an autoimmune condition in which the immune system mistakenly attacks myelin, the protective sheath around nerve fibers. This damage slows or blocks the signals traveling between the brain and the body. MS is most commonly diagnosed between ages 20 and 40 and affects women more often than men, though it can occur at any age. Symptoms vary widely and may include vision problems, muscle weakness, numbness or "pins and needles," trouble with balance and coordination, fatigue, and difficulties with thinking or memory. Many people have a relapsing course, in which symptoms flare and are then followed by remissions with reduced or no symptoms. There is no single specific test for MS; doctors use medical history, a neurological exam, MRI scans, and other tests to look for signs of nerve damage in different areas and at different times. There is no cure, but treatments can slow the disease and help control symptoms. Care is individualized and often combines medication with physical or occupational therapy. This is general information, not medical advice.

Frequently asked

What treats relapsing-remitting multiple sclerosis?

Our catalog lists 10 products that may treat relapsing-remitting multiple sclerosis, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is fingolimod hydrochloride.

What is the best-rated treatment for relapsing-remitting multiple sclerosis?

By our independent recall-safety rating — not an efficacy measure — fingolimod hydrochloride ranks highest among the products we list for relapsing-remitting multiple sclerosis. Always consult a professional.

How are these treatments ranked?

By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.

What types of drugs treat relapsing-remitting multiple sclerosis?

Treatments for relapsing-remitting multiple sclerosis span FDA drug classes including sphingosine 1-phosphate receptor modulator, pyrimidine synthesis inhibitor. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.